Cargando…

Upregulation of Apolipoprotein L6 Improves Tumor Immunotherapy by Inducing Immunogenic Cell Death

In the past few years, immune checkpoint blockade (ICB) therapy has emerged as a breakthrough treatment for cancers and has demonstrated inspiring effects in tumor patients with Epstein-Barr virus (EBV) infection. To allow more patients to benefit from immunotherapy, exploring novel biomarkers based...

Descripción completa

Detalles Bibliográficos
Autores principales:	Liu, Kecheng, Chen, Yutong, Li, Bixiang, Li, Yaning, Liang, Xinyue, Lin, Hai, Luo, Lisi, Chen, Tianliang, Dai, Yalan, Pang, Wenzheng, Zeng, Linjuan
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2023
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10046184/ https://www.ncbi.nlm.nih.gov/pubmed/36979348 http://dx.doi.org/10.3390/biom13030415

Ejemplares similares

S100A10 Promotes Pancreatic Ductal Adenocarcinoma Cells Proliferation, Migration and Adhesion through JNK/LAMB3-LAMC2 Axis
por: Lin, Hai, et al.
Publicado: (2022)

Molecular Classification of Genes Associated with Hypoxic Lipid Metabolism in Pancreatic Cancer
por: Li, Yaning, et al.
Publicado: (2022)

Immunogenic cell death in cancer immunotherapy
por: Choi, Minji, et al.
Publicado: (2023)

Immunogenic Cell Death and Immunotherapy of Multiple Myeloma
por: Serrano-del Valle, Alfonso, et al.
Publicado: (2019)

Commentary: Immunogenic Cell Death and Immunotherapy of Multiple Myeloma
por: Maes, Ken, et al.
Publicado: (2019)

Immunogenic cell death: The cornerstone of oncolytic viro-immunotherapy
por: Palanivelu, Lalitha, et al.
Publicado: (2023)

Engineering nanomedicines through boosting immunogenic cell death for improved cancer immunotherapy
por: Gao, Jing, et al.
Publicado: (2020)

Copper-induced injectable hydrogel with nitric oxide for enhanced immunotherapy by amplifying immunogenic cell death and regulating cancer associated fibroblasts
por: Shen, Shuilin, et al.
Publicado: (2023)

Response: Commentary: Immunogenic Cell Death and Immunotherapy of Multiple Myeloma
por: Serrano Del Valle, Alfonso, et al.
Publicado: (2019)

The role of immunogenic cell death in gastrointestinal cancer immunotherapy (Review)
por: Songjang, Worawat, et al.
Publicado: (2021)

Role of nanoparticle-mediated immunogenic cell death in cancer immunotherapy
por: Sun, Yajie, et al.
Publicado: (2021)

Nanotechnology-Assisted Immunogenic Cell Death for Effective Cancer Immunotherapy
por: Guo, Yichen, et al.
Publicado: (2023)

The Significance of Apolipoprotein-A in the Long-Term Death of Patients with STEMI
por: Lin, Guoli, et al.
Publicado: (2022)

Immunogenic Cell Death Activates the Tumor Immune Microenvironment to Boost the Immunotherapy Efficiency
por: Li, Zhilin, et al.
Publicado: (2022)

Identification of Immunogenic Cell Death-Related Signature for Glioma to Predict Survival and Response to Immunotherapy
por: Sun, Zhiqiang, et al.
Publicado: (2022)

Physical modalities inducing immunogenic tumor cell death for cancer immunotherapy
por: Adkins, Irena, et al.
Publicado: (2015)

Dying to Be Noticed: Epigenetic Regulation of Immunogenic Cell Death for Cancer Immunotherapy
por: Cruickshank, Brianne, et al.
Publicado: (2018)

Immunogenic cell death-related classifications guide prognosis and immunotherapy in osteosarcoma
por: Zong, Yuan, et al.
Publicado: (2023)

Identification of tumor antigens and immunogenic cell death-related subtypes for the improvement of immunotherapy of breast cancer
por: Cao, Xi, et al.
Publicado: (2022)

Immunogenic cell death related risk model to delineate ferroptosis pathway and predict immunotherapy response of patients with GBM
por: Feng, Songshan, et al.
Publicado: (2022)

Identification of immunogenic cell death-related signature on prognosis and immunotherapy in kidney renal clear cell carcinoma
por: Jiang, Silin, et al.
Publicado: (2023)

Substituted Benzamides Containing Azaspiro Rings as Upregulators of Apolipoprotein A-I Transcription
por: Du, Yu, et al.
Publicado: (2012)

Apolipoprotein D Upregulation in Alzheimer’s Disease but Not Frontotemporal Dementia
por: Bhatia, Surabhi, et al.
Publicado: (2018)

Immunogenic Cell Death Enhances Immunotherapy of Diffuse Intrinsic Pontine Glioma: From Preclinical to Clinical Studies
por: Liu, Guohao, et al.
Publicado: (2022)

Apolipoprotein E mimetic peptide protects against diffuse brain injury
por: Zhao, Yaning, et al.
Publicado: (2014)

Afzelin induces immunogenic cell death against lung cancer by targeting NQO2
por: Xia, Lei, et al.
Publicado: (2023)

Nano-enabled pancreas cancer immunotherapy using immunogenic cell death and reversing immunosuppression
por: Lu, Jianqin, et al.
Publicado: (2017)

Oncolytic virus immunotherapy induces immunogenic cell death and overcomes STING deficiency in melanoma
por: Bommareddy, Praveen K., et al.
Publicado: (2019)

Immunogenic Cell Death and Role of Nanomaterials Serving as Therapeutic Vaccine for Personalized Cancer Immunotherapy
por: Catanzaro, Elena, et al.
Publicado: (2022)

The prognostic value and response to immunotherapy of immunogenic cell death-associated genes in breast cancer
por: Zhao, Rongling, et al.
Publicado: (2023)

Combining immune checkpoint blockade with ATP-based immunogenic cell death amplifier for cancer chemo-immunotherapy
por: Zhang, Jiulong, et al.
Publicado: (2022)

Genomic analysis of immunogenic cell death-related subtypes for predicting prognosis and immunotherapy outcomes in glioblastoma multiforme
por: Liu, Zhiye, et al.
Publicado: (2023)

Stimuli-responsive nano vehicle enhances cancer immunotherapy by coordinating mitochondria-targeted immunogenic cell death and PD-L1 blockade
por: Li, Qiuyi, et al.
Publicado: (2022)

Immunogenic cell death-related classifications in breast cancer identify precise immunotherapy biomarkers and enable prognostic stratification
por: Wang, Xue, et al.
Publicado: (2022)

The Landscape of Cell Death Processes with Associated Immunogenic and Fibrogenic Effects in Arrhythmogenic Cardiomyopathy
por: Lu, Wenzhao, et al.
Publicado: (2022)

A novel immunogenic cell death–related subtype classification and risk signature for predicting prognosis and immunotherapy efficacy in gastric cancer
por: Dong, Bingqi, et al.
Publicado: (2023)

Comprehensive analysis of the immunogenic cell death-related signature for predicting prognosis and immunotherapy efficiency in patients with lung adenocarcinoma
por: Cui, Yingshu, et al.
Publicado: (2023)

Identification and validation of immunogenic cell death-related score in uveal melanoma to improve prediction of prognosis and response to immunotherapy
por: Li, Xiaoyan, et al.
Publicado: (2023)

Combination Cancer Immunotherapy of Nanoparticle-Based Immunogenic Cell Death Inducers and Immune Checkpoint Inhibitors
por: Qi, Jing, et al.
Publicado: (2021)

An immunogenic cell death-associated classification predictions are important for breast invasive carcinoma prognosis and immunotherapy
por: Liao, Xinghe, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_4tpbbvghl03cmni7f6dg8jfcig